Further, the treatment with the DDR1 inhibitor (DDR1in7rh), suppressed the growth of TICs at IC50 of 0.95 μM and that of the liver cancer cell line DIHXY at IC50 of 1.55 μM while PIL4 cells were four–fivefold less sensitive (Fig. 7d). Here, DDR1 is linked to liver cancer.